Catalyst Wire Dossier Catalyst Wire Dossier

Luseogliflozin

luseogliflozin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Luseogliflozin, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.

See pricing